Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-013878

Options or other derivatives

  • Executive Vice President acquired 130,718 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BOYER ANDREW S Executive Vice President 2026-03-02 Grant or award · Restricted Stock Units +65,359 65,359 D
BOYER ANDREW S Executive Vice President 2026-03-02 Grant or award · Performance-Based Restricted Stock Units +65,359 65,359 D
Loading xslF345X05/wk-form4_1772573190.xml…